Back

Multimodal atlas of human atherosclerosis links granular vascular cell states to coronary artery disease risk

Mosquera, J. V.; Tang, I.; Murach, M.; Auguste, G.; Kodali, A.; Hart, P.; Shaw, D. M.; Li, M.; Turner, A. W.; Hodonsky, C. J.; Dworak, N. M.; de Oliveira, A. K.; Sol-Church, K.; Jhee, T.; van der Sijs, K. I. M.; Adkar, S. S.; Choi, R. B.; Vacante, F.; Wu, J. C.; Cheng, P.; Giannarelli, C.; Leeper, N. J.; Finn, A. V.; Bjorkegren, J. L. M.; Kovacic, J. C.; Yurdagul, A.; van der Laan, S. W.; Miller, C. L.

2026-05-26 cardiovascular medicine
10.64898/2026.05.24.26353986 medRxiv
Show abstract

Advances in single-cell and spatial assays have revolutionized the scale and resolution of molecular tissue profiling. Here we present MetaPlaq, a multimodal atlas of human atherosclerotic arterial beds comprising over a million cells across single-cell transcriptomics, epigenomics and high-resolution spatial expression assays. We map granular cell states and disease-relevant transcriptional programs within the native tissue context of coronary arteries. Furthermore, we map cardiovascular GWAS signals to smooth muscle cells (SMCs) and endothelial cells (ECs) and uncover the cis-regulatory architecture governing their phenotypic transitions. Our comprehensive epigenomic reference allowed us to build cell-specific enhancer-gene link maps and multimodal gene regulatory networks (GRNs) underlying disease-relevant states such as osteogenic SMCs and ECs undergoing mesenchymal transition. We also integrate SMC and EC disease-associated gene sets with GRNs to nominate key transcription factors such as PRRX1, BNC2 and ELK3 regulating atherosclerosis-relevant transcriptional programs. Finally, we layer single-cell and spatial modalities to fine-map GWAS variants with improved cell and anatomical context. We highlight candidate cell-specific regulatory mechanisms at less characterized CAD loci, including FGD5 and MCF2L in ECs. Together, this atlas represents an important step towards fully interpreting genetic risk loci and informing new therapeutic strategies for cardiovascular disease.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Nature
575 papers in training set
Top 0.7%
23.1%
2
Nature Genetics
240 papers in training set
Top 0.2%
19.2%
3
Nature Communications
4913 papers in training set
Top 9%
15.1%
50% of probability mass above
4
Cell Genomics
162 papers in training set
Top 0.5%
6.5%
5
Science
429 papers in training set
Top 7%
4.4%
6
Nature Cardiovascular Research
28 papers in training set
Top 0.1%
4.1%
7
Cell
370 papers in training set
Top 5%
4.0%
8
Circulation
66 papers in training set
Top 1.0%
3.7%
9
Developmental Cell
168 papers in training set
Top 7%
2.5%
10
Genome Medicine
154 papers in training set
Top 5%
1.5%
11
eLife
5422 papers in training set
Top 53%
0.9%
12
Journal of Clinical Investigation
164 papers in training set
Top 6%
0.8%
13
Circulation: Genomic and Precision Medicine
42 papers in training set
Top 1%
0.8%
14
Nature Medicine
117 papers in training set
Top 5%
0.8%
15
Neuron
282 papers in training set
Top 8%
0.8%
16
Scientific Reports
3102 papers in training set
Top 77%
0.7%
17
EMBO Molecular Medicine
85 papers in training set
Top 5%
0.7%
18
The EMBO Journal
267 papers in training set
Top 6%
0.7%
19
JCI Insight
241 papers in training set
Top 8%
0.7%
20
Cell Reports Methods
141 papers in training set
Top 7%
0.5%
21
Science Translational Medicine
111 papers in training set
Top 8%
0.5%
22
Circulation Research
39 papers in training set
Top 1%
0.5%
23
Nature Cell Biology
99 papers in training set
Top 6%
0.5%